Skip to content

Parexel reported eying sale

May 9, 2017

Contract drug research firm Parexel International Corp (PRXL.O) is exploring a sale, sources familiar with the matter told Reuters on Monday.

Boston-based Parexel had a market value of about $3.51 billion as of Friday’s close. The company’s stock rose as much as 10.2 percent to $75.87 in morning trading.

The Wall Street Journal first reported about the talks, saying Parexel is working with investment bankers to sound out potential buyers, including private-equity firms, citing sources familiar with the matter. (on.wsj.com/2pdsziP)

http://reut.rs/2pWP62o

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: